Modern cardiovascular therapies offer unprecedented opportunities to improve survival and quality of life. Cardiovascular morbidity and mortality have significantly declined, owing in a large part to preventive therapies and technological advances such as coronary revascularization, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). Newer therapies like transcatheter aortic valve replacement hold great promise. Nonetheless, cardiovascular disease remains a leading cause of death.
Kirkpatrick JN, Hauptman PJ, Goodlin SJ. Bundling Informed Consent and Advance Care Planning in Chronic Cardiovascular Disease: We Need to Talk. JAMA Intern Med. 2015;175(1):5–6. doi:10.1001/jamainternmed.2014.6219
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: